Boosting the diagnostic power of amyloid-β PET using a data-driven spatially informed classifier for decision support
Abstract Background Amyloid-β (Aβ) PET has emerged as clinically useful for more accurate diagnosis of patients with cognitive decline. Aβ deposition is a necessary cause or response to the cellular pathology of Alzheimer’s disease (AD). Usual clinical and research interpretation of amyloid PET does...
Saved in:
Main Authors: | Ashwin V. Venkataraman, Wenjia Bai, Alex Whittington, James F. Myers, Eugenii A. Rabiner, Anne Lingford-Hughes, Paul M. Matthews, for the Alzheimer’s Disease Neuroimaging Initiative |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/232b9cbd125145b38e07fa18b48eaefd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Amyloid
Published: (1994) -
11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
by: Youn YC, et al.
Published: (2017) -
β-Barrels and Amyloids: Structural Transitions, Biological Functions, and Pathogenesis
by: Anna I. Sulatskaya, et al.
Published: (2021) -
Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
by: Rebecca M. Parodi-Rullán, et al.
Published: (2021) -
Spatial Patterns of Amyloid Deposition in Patients with Chronic Focal or Diffuse Traumatic Brain Injury Using 18F-FPYBF-2 PET
by: Ubukata S, et al.
Published: (2020)